QQ客服 官方微博 反馈留言

	Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases
	He Weiwei[1]; Wang Bin[2]; Li Qian[3]; Yao Qiuming[4]; Jia Xi[5]; Song Ronghua[6]; Li Sheli[7]; Zhang Jin-An[8]
刊名	Frontiers in immunology
	2019
卷号	10页码:261
关键词	CD160 Graves' disease autoimmune diseases co-inhibitory molecules co-stimulatory molecules
ISSN号	1664-3224
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2162582
专题	上海大学
作者单位	1.[1]Department of Endocrinology, Affiliated Hospital of Yanan Medical University, Yanan, China. 2.[2]Department of Endocrinology, Jinshan Hospital of Fudan University, Shanghai, China. 3.[3]Department of Endocrinology, Jinshan Hospital of Fudan University, Shanghai, China. 4.[4]Department of Endocrinology, Jinshan Hospital of Fudan University, Shanghai, China. 5.[5]Department of Endocrinology, Jinshan Hospital of Fudan University, Shanghai, China. 6.[6]Department of Endocrinology and Rheumatology, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China. 7.[7]Department of Endocrinology, Affiliated Hospital of Yanan Medical University, Yanan, China. 8.[8]Department of Endocrinology and Rheumatology, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.
推荐引用方式 GB/T 7714	He Weiwei[1],Wang Bin[2],Li Qian[3],et al. Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases[J]. Frontiers in immunology,2019,10:261.
APA	He Weiwei[1].,Wang Bin[2].,Li Qian[3].,Yao Qiuming[4].,Jia Xi[5].,...&Zhang Jin-An[8].(2019).Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases.Frontiers in immunology,10,261.
MLA	He Weiwei[1],et al."Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases".Frontiers in immunology 10(2019):261.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。